ZLZhaohua Li

Zhaohua Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zhaohua Li has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Changsheng Yan

    Department of Gastroenterology Zhongshan Hospital Xiamen University Xiamen, Fujian China

    1 shared publication
  • Chuanxing Xiao

    Department of Gastroenterology Zhongshan Hospital Xiamen University Xiamen, Fujian China

    1 shared publication
  • Dajun Chen

    Department of Gastroenterology People's Hospital of Quzhou Quzhou, Zhejiang China

    1 shared publication
  • Hongzhi Xu

    Engineering Technology Research Institute of China National Petroleum Corporation, Binhai District, Tianjin, China 300451

    1 shared publication
  • Qingwen Huang

    Department of Gastroenterology Zhongshan Hospital Xiamen University Xiamen, Fujian China

    1 shared publication
  • Yanyun Fan

    Department of Gastroenterology Zhongshan Hospital Xiamen University Xiamen, Fujian China

    1 shared publication

Latest Publications

  • Knockdown of pseudogene derived from lncRNA DUXAP10 inhibits cell proliferation, migration, invasion, and promotes apoptosis in pancreatic cancer

    by Yifan Lian, Chuanxing Xiao, Changsheng Yan, Dajun Chen, Qingwen Huang, Yanyun Fan, Zhaohua Li, Hongzhi Xu

    Current evidence suggests that pseudogene derived lncRNAs may be important players in human cancer progression. Our previous study showed that DUXAP10 could promote cell proliferation in colorectal cancer. However, the clinical significance and potential role of DUXAP10 in human pancreatic cancer (PC) has not been uncovered. In this study, we found that DUXAP10 was overexpressed in PC tissues compared with normal tissues. DUXAP10 expression was significantly higher in patients with an advanced TNM stage and positive lymph node metastasis. Bioinformatic analysis showed that cell cycle progression was increased in patients with high DUXAP10 expression. In vitro and in vivo assays of DUXAP10 alterations revealed a complex integrated phenotype affecting cell growth, apoptosis, migration, and invasion. Mechanistic studies revealed that DUXAP10 has a crucial role in G2/M arrest. We further showed that DUXAP10 regulated PC cell proliferation through interact with RNA‐binding protein EZH2 and LSD1. Overall, our findings indicates that DUXAP10 is an oncogenic lncRNA that promotes PC proliferation and metastasis.